What happens once Phase 1 vaccine clinics wrap up? Ensuring access to next doses
By
Kimberly Bonvissuto
Alicia Lasek
Feb 10, 2021
Industry advocates and the CDC answer key questions: How to facilitate a smooth transition to a new vaccine supplier; and how to guarantee second doses for staff and residents who receive their first dose...
Questions to ponder as herd immunity remains out of reach
By
Steven Fuller, Ph.D., DO
Feb 08, 2021
Experts estimate that herd immunity for COVID-19 will be reached when 75–85% of the U.S. population has received the COVID-19 vaccine. But long-term care — including nursing homes and assisted...
Makers of newer vaccines tout advantages as trial results and approvals announced
By
Alicia Lasek
Feb 01, 2021
Two drugmakers say their vaccines, which include J&J’s one-dose candidate, are effective against new coronavirus variants, while AstraZeneca’s vaccine is now approved for adults across the...